New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 6, 2019 - Akorn launched an AB-rated generic version of Bausch Health’s Lotemax (loteprednol etabonate) 0.5% ophthalmic suspension.
Download PDF
Return to publications
